Nordic Nanovector ASA (0R6Y)

23.52
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    23.52 - 23.52

0R6Y Overview

Prev. Close
22.52
Day's Range
23.52-23.52
Revenue
-
Open
23.63
52 wk Range
13-31.82
EPS
-
Volume
0
Market Cap
2.3B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
14,888
P/E Ratio
-
Beta
-
1-Year Change
6.19%
Shares Outstanding
98,078,380
Next Earnings Date
18 Nov 2021
What is your sentiment on Nordic Nanovector ASA?
or
Vote to see community's results!

Nordic Nanovector ASA News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsBuyBuyNeutralStrong BuyBuy
SummaryStrong BuyStrong BuyBuyStrong BuyNeutral

Nordic Nanovector ASA Company Profile

Nordic Nanovector ASA Company Profile

Employees
39
Market
Norway

Nordic Nanovector ASA is a Norway-based company active in the biotechnology industry. It is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product candidate is Betalutin, comprising a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide (Lutetium 177). It is designed improve treatment of Non-Hodgkin Lymphoma (NHL) and advanced through clinical development. Additionally, the Company is engaged in the development of its Antibody-Radionuclide-Conjugate (ARC) portfolio to treat various selected cancer indications. It has two subsidiaries, Nordic Nanovector GmbH and Nordic Nanovector Ltd.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.